Delaware
|
|
001-15405
|
|
77-0518772
|
(State or other Jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer
|
of Incorporation)
|
|
|
|
Identification No.)
|
|
|
|
|
|
Exhibit No.
|
|
Description
|
|
|
|
|
Condensed consolidated statements of operations for the fiscal quarters ended January 31, April 30, July 31, and October 31, 2017 and 2018. Condensed consolidated statements of operations for the six months ended April 30, 2017 and 2018. Condensed consolidated statements of operations for the nine months ended July 31, 2017 and 2018. Condensed consolidated statements of operations for the fiscal years ended October 31, 2017 and 2018.
Selected segment information for the fiscal quarters ended January 31, 2017 and 2018, April 30, 2017 and 2018, July 31, 2017 and 2018 and October 31, 2017 and 2018 and fiscal years ended October 31, 2017 and 2018.
|
|
||
|
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|
|
|
|
|
|
|
|
By:
|
/s/ P. Diana Chiu
|
|
Name:
|
P. Diana Chiu
|
|
Title:
|
Vice President, Assistant General Counsel and
|
|
|
Assistant Secretary
|
|
|
|
|
|
|
Date: January 25, 2019
|
|
Exhibit No.
|
|
Description
|
|
|
|
|
99.1
|
|
|
Condensed consolidated statements of operations for the fiscal quarters ended January 31, April 30, July 31, and October 31, 2017 and 2018. Condensed consolidated statements of operations for the six months ended April 30, 2017 and 2018. Condensed consolidated statements of operations for the nine months ended July 31, 2017 and 2018. Condensed consolidated statements of operations for the fiscal years ended October 31, 2017 and 2018.
Selected segment information for the fiscal quarters ended January 31, 2017 and 2018, April 30, 2017 and 2018, July 31, 2017 and 2018 and October 31, 2017 and 2018 and fiscal years ended October 31, 2017 and 2018.
|
|
|
Three Months Ended
|
|
||||||||
|
|
January 31, 2018
|
|
||||||||
|
|
As Previously Reported
|
|
Pension Adjustment
|
|
As Adjusted
|
|
||||
|
|
|
|
|
|
|
|
||||
Net revenue
|
|
$
|
1,211
|
|
|
|
|
$
|
1,211
|
|
|
|
|
|
|
|
|
|
|
||||
Costs and expenses:
|
|
|
|
|
|
|
|
||||
Cost of products and services
|
|
538
|
|
|
3
|
|
541
|
|
|
||
Research and development
|
|
93
|
|
|
1
|
|
94
|
|
|
||
Selling, general and administrative
|
|
341
|
|
|
6
|
|
347
|
|
|
||
Total costs and expenses
|
|
972
|
|
|
|
|
982
|
|
|
||
|
|
|
|
|
|
|
|
||||
Income from operations
|
|
239
|
|
|
|
|
229
|
|
|
||
|
|
|
|
|
|
|
|
||||
Interest income
|
|
9
|
|
|
|
|
9
|
|
|
||
Interest expense
|
|
(20
|
)
|
|
|
|
(20
|
)
|
|
||
Other income (expense), net
|
|
5
|
|
|
10
|
|
15
|
|
|
||
|
|
|
|
|
|
|
|
||||
Income before taxes
|
|
233
|
|
|
|
|
233
|
|
|
||
|
|
|
|
|
|
|
|
||||
Provision for income taxes
|
|
553
|
|
|
|
|
553
|
|
|
||
|
|
|
|
|
|
|
|
||||
Net loss
|
|
$
|
(320
|
)
|
|
|
|
$
|
(320
|
)
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
||||
Net loss per share:
|
|
|
|
|
|
|
|
||||
Basic
|
|
$
|
(0.99
|
)
|
|
|
|
$
|
(0.99
|
)
|
|
Diluted
|
|
$
|
(0.99
|
)
|
|
|
|
$
|
(0.99
|
)
|
|
|
|
|
|
|
|
|
|
||||
Weighted average shares used in computing net loss per share:
|
|
|
|
|
|
|
|
||||
Basic
|
|
323
|
|
|
|
|
323
|
|
|
||
Diluted
|
|
323
|
|
|
|
|
323
|
|
|
||
|
|
|
|
|
|
|
|
||||
Cash dividends declared per common share
|
|
$
|
0.149
|
|
|
|
|
$
|
0.149
|
|
|
|
|
Three Months Ended
|
|
||||||||
|
|
January 31, 2017
|
|
||||||||
|
|
As Previously Reported
|
|
Pension Adjustment
|
|
As Adjusted
|
|
||||
|
|
|
|
|
|
|
|
||||
Net revenue
|
|
$
|
1,067
|
|
|
|
|
$
|
1,067
|
|
|
|
|
|
|
|
|
|
|
||||
Costs and expenses:
|
|
|
|
|
|
|
|
||||
Cost of products and services
|
|
493
|
|
|
10
|
|
503
|
|
|
||
Research and development
|
|
79
|
|
|
3
|
|
82
|
|
|
||
Selling, general and administrative
|
|
289
|
|
|
19
|
|
308
|
|
|
||
Total costs and expenses
|
|
861
|
|
|
|
|
893
|
|
|
||
|
|
|
|
|
|
|
|
||||
Income from operations
|
|
206
|
|
|
|
|
174
|
|
|
||
|
|
|
|
|
|
|
|
||||
Interest income
|
|
4
|
|
|
|
|
4
|
|
|
||
Interest expense
|
|
(20
|
)
|
|
|
|
(20
|
)
|
|
||
Other income (expense), net
|
|
3
|
|
|
32
|
|
35
|
|
|
||
|
|
|
|
|
|
|
|
||||
Income before taxes
|
|
193
|
|
|
|
|
193
|
|
|
||
|
|
|
|
|
|
|
|
||||
Provision for income taxes
|
|
25
|
|
|
|
|
25
|
|
|
||
|
|
|
|
|
|
|
|
||||
Net income
|
|
$
|
168
|
|
|
|
|
$
|
168
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
||||
Net income per share:
|
|
|
|
|
|
|
|
||||
Basic
|
|
$
|
0.52
|
|
|
|
|
$
|
0.52
|
|
|
Diluted
|
|
$
|
0.52
|
|
|
|
|
$
|
0.52
|
|
|
|
|
|
|
|
|
|
|
||||
Weighted average shares used in computing net income per share:
|
|
|
|
|
|
|
|
||||
Basic
|
|
322
|
|
|
|
|
322
|
|
|
||
Diluted
|
|
326
|
|
|
|
|
326
|
|
|
||
|
|
|
|
|
|
|
|
||||
Cash dividends declared per common share
|
|
$
|
0.132
|
|
|
|
|
$
|
0.132
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|||||||||||||||||||||
LIFE SCIENCES AND APPLIED MARKETS SEGMENT
|
|||||||||||||||||||||
(Unaudited)
|
|||||||||||||||||||||
|
|||||||||||||||||||||
All periods below were revised to include the impact of the adoption of ASU 2017-07.
|
|||||||||||||||||||||
|
|||||||||||||||||||||
(In millions, except margins data)
|
|
2018
|
|||||||||||||||||||
|
|
|
Q1
|
|
Q2
|
|
Q3
|
|
Q4
|
|
Total
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Gross margin %
|
|
62.1
|
%
|
|
59.7
|
%
|
|
61.3
|
%
|
|
62.1
|
%
|
|
61.3
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Research and development expenses
|
|
$
|
54
|
|
|
$
|
54
|
|
|
$
|
54
|
|
|
$
|
58
|
|
|
$
|
220
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Selling, general and administrative expenses
|
|
$
|
162
|
|
|
$
|
154
|
|
|
$
|
155
|
|
|
$
|
159
|
|
|
$
|
630
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Income from operations
|
|
$
|
154
|
|
|
$
|
113
|
|
|
$
|
122
|
|
|
$
|
154
|
|
|
$
|
543
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Operating margin %
|
|
25.9
|
%
|
|
21.0
|
%
|
|
22.7
|
%
|
|
25.7
|
%
|
|
23.9
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
2017
|
||||||||||||||||||
|
|
|
Q1
|
|
Q2
|
|
Q3
|
|
Q4
|
|
Total
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Gross margin %
|
|
59.9
|
%
|
|
60.2
|
%
|
|
60.0
|
%
|
|
61.2
|
%
|
|
60.3
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Research and development expenses
|
|
$
|
48
|
|
|
$
|
50
|
|
|
$
|
50
|
|
|
$
|
51
|
|
|
$
|
199
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Selling, general and administrative expenses
|
|
$
|
141
|
|
|
$
|
145
|
|
|
$
|
147
|
|
|
$
|
154
|
|
|
$
|
587
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Income from operations
|
|
$
|
123
|
|
|
$
|
106
|
|
|
$
|
109
|
|
|
$
|
132
|
|
|
$
|
470
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Operating margin %
|
|
23.6
|
%
|
|
21.3
|
%
|
|
21.5
|
%
|
|
23.9
|
%
|
|
22.6
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|||||||||||||||||||||
DIAGNOSTICS AND GENOMICS SEGMENT
|
|||||||||||||||||||||
(Unaudited)
|
|||||||||||||||||||||
|
|||||||||||||||||||||
All periods below were revised to include the impact of the adoption of ASU 2017-07.
|
|||||||||||||||||||||
|
|||||||||||||||||||||
(In millions, except margins data)
|
|
2018
|
|||||||||||||||||||
|
|
|
Q1
|
|
Q2
|
|
Q3
|
|
Q4
|
|
Total
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Gross margin %
|
|
54.2
|
%
|
|
54.8
|
%
|
|
56.8
|
%
|
|
59.0
|
%
|
|
56.3
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Research and development expenses
|
|
$
|
25
|
|
|
$
|
24
|
|
|
$
|
30
|
|
|
$
|
30
|
|
|
$
|
109
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Selling, general and administrative expenses
|
|
$
|
63
|
|
|
$
|
61
|
|
|
$
|
62
|
|
|
$
|
63
|
|
|
$
|
249
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Income from operations
|
|
$
|
24
|
|
|
$
|
48
|
|
|
$
|
43
|
|
|
$
|
58
|
|
|
$
|
173
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Operating margin %
|
|
11.7
|
%
|
|
19.9
|
%
|
|
18.0
|
%
|
|
22.7
|
%
|
|
18.4
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
2017
|
||||||||||||||||||
|
|
|
Q1
|
|
Q2
|
|
Q3
|
|
Q4
|
|
Total
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Gross margin %
|
|
54.6
|
%
|
|
57.5
|
%
|
|
52.8
|
%
|
|
55.6
|
%
|
|
55.2
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Research and development expenses
|
|
$
|
21
|
|
|
$
|
21
|
|
|
$
|
24
|
|
|
$
|
23
|
|
|
$
|
89
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Selling, general and administrative expenses
|
|
$
|
52
|
|
|
$
|
55
|
|
|
$
|
54
|
|
|
$
|
57
|
|
|
$
|
218
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Income from operations
|
|
$
|
27
|
|
|
$
|
53
|
|
|
$
|
37
|
|
|
$
|
50
|
|
|
$
|
167
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Operating margin %
|
|
14.7
|
%
|
|
23.7
|
%
|
|
17.0
|
%
|
|
21.3
|
%
|
|
19.4
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|||||||||||||||||||||
AGILENT CROSSLAB SEGMENT
|
|||||||||||||||||||||
(Unaudited)
|
|||||||||||||||||||||
|
|||||||||||||||||||||
All periods below were revised to include the impact of the adoption of ASU 2017-07.
|
|||||||||||||||||||||
|
|||||||||||||||||||||
(In millions, except margins data)
|
|
2018
|
|||||||||||||||||||
|
|
|
Q1
|
|
Q2
|
|
Q3
|
|
Q4
|
|
Total
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Gross margin %
|
|
50.4
|
%
|
|
50.0
|
%
|
|
50.1
|
%
|
|
51.0
|
%
|
|
50.4
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Research and development expenses
|
|
$
|
14
|
|
|
$
|
14
|
|
|
$
|
13
|
|
|
$
|
15
|
|
|
$
|
56
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Selling, general and administrative expenses
|
|
$
|
105
|
|
|
$
|
103
|
|
|
$
|
102
|
|
|
$
|
103
|
|
|
$
|
413
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Income from operations
|
|
$
|
87
|
|
|
$
|
96
|
|
|
$
|
98
|
|
|
$
|
107
|
|
|
$
|
388
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Operating margin %
|
|
21.2
|
%
|
|
22.5
|
%
|
|
23.1
|
%
|
|
24.2
|
%
|
|
22.8
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
2017
|
||||||||||||||||||
|
|
|
Q1
|
|
Q2
|
|
Q3
|
|
Q4
|
|
Total
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Gross margin %
|
|
48.5
|
%
|
|
49.6
|
%
|
|
49.9
|
%
|
|
49.6
|
%
|
|
49.4
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Research and development expenses
|
|
$
|
12
|
|
|
$
|
12
|
|
|
$
|
12
|
|
|
$
|
14
|
|
|
$
|
50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Selling, general and administrative expenses
|
|
$
|
91
|
|
|
$
|
94
|
|
|
$
|
91
|
|
|
$
|
95
|
|
|
$
|
371
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Income from operations
|
|
$
|
73
|
|
|
$
|
81
|
|
|
$
|
90
|
|
|
$
|
92
|
|
|
$
|
336
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Operating margin %
|
|
20.1
|
%
|
|
21.5
|
%
|
|
23.2
|
%
|
|
22.7
|
%
|
|
21.9
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|